In this study, we investigated an easily applicable, less burdensome ex vivo stimulation method to measure GR sensitivity alterations in patients with depression based on published protocols (Bellingrath et al. 2013; Burnsides et al. 2012; Smits et al. 1998; ter Wolbeek et al. 2008). Here, NR3C1 is linked to depressive disorder.